Scientific deep-dive

Knee Bursitis and Body Weight: Pes Anserine Bursitis, Diabetes and the Evidence

Knee bursitis explained, with a focus on pes anserine bursitis on the inner knee. What the evidence shows about knee arthritis, diabetes and body weight as risk factors, diagnosis, steroid shots versus physical therapy, and whether weight loss or GLP-1 drugs help.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
10 min read·13 citations

Knee bursitis is swelling or irritation of one of the small fluid-filled sacs (bursae) that cushion tendons and skin around the knee. In adults with extra weight, the one that matters most is the pes anserine bursa, on the inner side of the knee a few inches below the joint line. It shows up far more often in people with knee arthritis [1][2] and in people with type 2 diabetes [5]. The direct evidence that body weight itself causes it is surprisingly thin, and in two studies that checked, people with the condition were not heavier than those without it [5][7]. This review covers the symptoms, who gets it, how the treatments compare, and where weight loss fits.

About this article

This is an evidence review, not a treatment guide. Most research on pes anserine bursitis is small, and much of it comes from clinics that see people with knee arthritis. The links with weight and diabetes come from cross-sectional and case-control studies, which show associations rather than cause. No trial has tested weight loss or a GLP-1 drug as a treatment for any kind of knee bursitis, and we say so where it matters.

The honest summary

  • It travels with knee arthritis. In a community MRI study, anserine bursitis was found in 17.5% of people with knee arthritis versus 2.2% without it [1]. In a clinic study, 1 in 5 arthritic knees showed it on ultrasound [2].
  • Diabetes is linked to it. Over a third of people with type 2 diabetes in one clinic study had it [5], and diabetes roughly doubled the odds of bursitis or tendinitis in another [6].
  • The weight link is weaker than its reputation. BMI did not differ between people with and without it in two studies [5][7].
  • A diagnosis by touch alone is often wrong. Compared with MRI, a clinical diagnosis was right well under half the time [3].
  • A steroid shot is not clearly better than other care. One trial found no advantage over placebo [9]; another found physical therapy worked as well [10].
  • Weight loss helps the knee it usually comes with. Each kilogram lost reduces knee load during walking [8], and a GLP-1 trial cut arthritis pain [13]. Neither tested bursitis itself.

Which bursa? The two common types of knee bursitis

Pes anserine bursitis sits on the inner (medial) side of the shin bone, just below the knee, where three tendons from the thigh attach. It causes pain and tenderness at that spot, and it is mostly seen in middle-aged and older adults with knee arthritis. Doctors often call it pes anserine tendinitis-bursitis syndrome, because the tendons and the bursa are hard to tell apart on examination.

Prepatellar bursitis is a swelling on the front of the kneecap. Repeated kneeling is the most common cause of this kind of surface bursitis, and it can also follow a direct blow, gout or infection [11]. In a random sample of 3,710 French workers it was uncommon (0.6% of men and 0.2% of women), clustered in construction and food processing, and concentrated among men doing heavy work with frequent kneeling [12]. Body weight is not the main story here; what you do with your knees is.

A third swelling, the Baker's cyst behind the knee, was the most common finding of all in the community MRI study (27.9%) and was also more frequent in people with knee pain [1]. It is usually a sign of something going on inside the joint rather than a separate bursitis.

Who gets pes anserine bursitis?

Knee arthritis, women and age

In the Hallym Aging Study, a Korean population sample of 358 people with an average age of 72, anserine bursitis on MRI was far more common in people with radiographic knee arthritis (17.5% versus 2.2%) and in people with knee pain (14.4% versus 2.5%) [1]. A Turkish ultrasound study of 85 people with symptomatic knee arthritis found it in 20% of knees. It was more common in women and older patients, and the bursa was larger in more advanced arthritis [2].

Magnitude comparison

Share of people or knees with pes anserine bursitis in imaging studies. Percentages, not a direct comparison between studies.[1][2]

  • No knee arthritis (MRI, community)2.2 %
    Hallym Aging Study
  • No knee pain (MRI, community)2.5 %
    Hallym Aging Study
  • Knee pain (MRI, community)14.4 %
    Hallym Aging Study
  • Knee arthritis (MRI, community)17.5 %
    Hallym Aging Study
  • Arthritic knees with symptoms (ultrasound)20 %
    Turkish clinic study
Share of people or knees with pes anserine bursitis in imaging studies. Percentages, not a direct comparison between studies.

It also seems to matter for the course of arthritis. In the US Osteoarthritis Initiative, tenderness over the anserine bursa was linked to more frequent knee pain later (OR 2.28) and to a higher chance of knee replacement (OR 1.54), even after the analysis accounted for age, sex, BMI and arthritis severity [4]. That does not mean the bursa causes the arthritis to progress; more likely, tenderness there is a marker of a knee under more strain.

Diabetes

An Israeli clinic study examined 94 people with type 2 diabetes and found anserine bursitis in 34 of them (36%), 91% of whom were women [5]. Within that group, age, BMI, diabetes duration and blood sugar control did not differ between those with and without bursitis. In a Puerto Rican study of 202 adults, people with diabetes had 2.47 times the odds of some form of bursitis or tendinitis, and anserine bursitis was among the conditions seen more often [6]. Both studies were small and cross-sectional.

Body weight

This is where the evidence gets thin. The bursitis is often described as a problem of heavier women with knee arthritis, and the people who get it do tend to fit that profile. But in a Mexican case-control study of 22 women with the condition and 38 matched controls, obesity, diabetes and knee arthritis were no more common in the cases; the one factor that stood out was a knock-kneed (valgus) alignment, with about 5 times the odds [7]. In the diabetes study above, BMI was the same in people with and without bursitis [5].

The fair reading is that extra weight sits upstream of the things most clearly tied to pes anserine bursitis, above all knee arthritis, rather than being a strong independent cause on its own. The hip shows a similar pattern: in hip bursitis and gluteal tendinopathy, BMI also stopped mattering once knee arthritis and back pain were taken into account.

Getting the diagnosis right

Pain on the inner knee is not always the bursa. In a study of 156 patients who all had knee MRI, the bedside diagnosis of pes anserine syndrome had a sensitivity of 41.2% and a specificity of 59.5% against the scan [3]. The patients labeled with the syndrome mainly had a narrower inner joint space, which points back to arthritis. The authors suggested imaging before invasive treatment such as an injection. Ultrasound is a practical way to see the bursa itself [2].

When knee swelling needs prompt care

A hot, red, swollen bursa, especially over the kneecap with a skin break or fever, can be infected. Infected bursitis is treated with antibiotics, and draining or surgery is reserved for cases that do not respond [11]. Do not wait it out.

Treatment: what the trials show

The trials are small. In a Mexican randomized trial of 58 adults with anserine syndrome who were also taking diclofenac, an injection of methylprednisolone plus lidocaine was no better than an injection of local anesthetic and water: pain and function scores improved by about 62% in both groups after four weeks [9]. In a Turkish study of 60 people with knee arthritis and pes anserine bursitis, physical therapy and a steroid injection both improved pain, function and walking tests over eight weeks, with no difference between them [10]. The same study found that people with the bursitis had more pain and disability than those with knee arthritis alone [10].

For prepatellar bursitis from kneeling, the usual approach is conservative care and removing the cause. Draining it is generally not recommended for this type because of the risk of introducing infection, and there is no high-quality evidence that a steroid injection helps [11]. Knee pads and less time kneeling are the practical levers.

Does losing weight help knee bursitis?

No study has tested weight loss as a treatment for pes anserine or prepatellar bursitis. What is known is about the knee as a whole. In an 18-month diet and exercise trial in 142 older adults with knee arthritis and overweight or obesity, each kilogram of weight lost was linked to roughly 4 kilograms less load on the knee with every step [8]. Over thousands of steps a day, that adds up.

Because pes anserine bursitis is so tied to knee arthritis, easing the arthritis is a reasonable indirect target. But the bursa sits outside the joint, where the tendons pull rather than where the bones press, so it would be wrong to assume the load benefit transfers one for one. For the arthritis itself, the evidence for weight loss is much stronger; see semaglutide and knee osteoarthritis (STEP 9).

What about GLP-1 drugs?

As of October 2026, no published study has looked at semaglutide, tirzepatide or any other GLP-1 drug in knee bursitis. The closest evidence is the STEP 9 trial in 407 people with obesity and knee arthritis: over 68 weeks, weight fell 13.7% with semaglutide and 3.2% with placebo, and the knee arthritis pain score improved by 41.7 points versus 27.5 points on a 100-point scale [13]. That trial did not look at bursitis. Any benefit for the bursa would be indirect, through weight and arthritis, and remains untested. If knee arthritis is advanced enough that surgery is being discussed, see BMI cutoffs for knee and hip replacement.

Practical guidance

  • Locate the pain. Inner knee below the joint line points to the pes anserine area; a soft swelling on the front of the kneecap points to prepatellar bursitis.
  • Ask about imaging before an injection. A diagnosis by touch alone is often wrong [3].
  • Physical therapy is a fair first option. It matched a steroid shot in one trial [10], and the shot did not beat placebo in another [9].
  • If you kneel for work, protect the kneecap. Kneeling is the main driver of prepatellar bursitis [11][12].
  • Treat weight loss as help for the knee, not a cure for the bursa. It lightens knee load [8] and eased arthritis pain in a GLP-1 trial [13], but it has not been tested for bursitis.
  • If you have diabetes, mention knee pain. Bursitis is more common with diabetes [5][6].

Frequently Asked Questions

It is irritation of a small fluid-filled sac on the inner side of the shin bone, just below the knee, where three tendons from the thigh attach. It causes pain and tenderness at that spot. It is most common in middle-aged and older women with knee arthritis.
Not directly, as far as the evidence shows. Pes anserine bursitis is strongly linked to knee arthritis and to type 2 diabetes, and extra weight raises the risk of both. But in two studies that compared people with and without the bursitis, body weight or BMI did not differ. Prepatellar bursitis is driven mostly by repeated kneeling.
It has not been tested. Weight loss reduces the load on the knee with every step and improves knee arthritis pain, which often comes with this bursitis. Any benefit for the bursa itself would be indirect, so it works best as part of a plan that also includes physical therapy.
Not clearly. In one small trial a steroid injection was no better than a placebo injection for pes anserine bursitis, and in another, physical therapy worked as well as the injection. Infected bursitis is different and needs antibiotics.

References

  1. 1.Kim IJ, Kim DH, Song YW, Guermazi A, Crema MD, Hunter DJ, et al. The prevalence of periarticular lesions detected on magnetic resonance imaging in middle-aged and elderly persons: a cross-sectional study. BMC Musculoskelet Disord. 2016. PMID: 27117911.
  2. 2.Uysal F, Akbal A, Gökmen F, Adam G, Reşorlu M. Prevalence of pes anserine bursitis in symptomatic osteoarthritis patients: an ultrasonographic prospective study. Clin Rheumatol. 2015. PMID: 24797774.
  3. 3.Atici A, Bahadir Ulger FE, Akpinar P, Illeez OG, Geler Kulcu D, Unlu Ozkan F, et al. Poor Accuracy of Clinical Diagnosis in Pes Anserine Tendinitis Bursitis Syndrome. Indian J Orthop. 2022. PMID: 35070151.
  4. 4.Xiong T, Lin C, Deng X, Chen S, Ou Y, Cheng T, et al. Anserine bursa palpation tenderness is a risk factor for knee osteoarthritis progression and arthroplasty: data from the Osteoarthritis Initiative. Clin Rheumatol. 2023. PMID: 36372850.
  5. 5.Cohen SE, Mahul O, Meir R, Rubinow A. Anserine bursitis and non-insulin dependent diabetes mellitus. J Rheumatol. 1997. PMID: 9375878.
  6. 6.Font YM, Castro-Santana LE, Nieves-Plaza M, Maldonado M, Mayor AM, Vilá LM. Factors associated with regional rheumatic pain disorders in a population of Puerto Ricans with diabetes mellitus. Clin Rheumatol. 2014. PMID: 24522480.
  7. 7.Alvarez-Nemegyei J. Risk factors for pes anserinus tendinitis/bursitis syndrome: a case control study. J Clin Rheumatol. 2007. PMID: 17414530.
  8. 8.Messier SP, Gutekunst DJ, Davis C, DeVita P. Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis. Arthritis Rheum. 2005. PMID: 15986358.
  9. 9.Vega-Morales D, Esquivel-Valerio JA, Negrete-López R, Galarza-Delgado DÁ, Garza-Elizondo MA. Safety and efficacy of methylprednisolone infiltration in anserine syndrome treatment. Reumatol Clin. 2012. PMID: 22317851.
  10. 10.Sarifakioglu B, Afsar SI, Yalbuzdag SA, Ustaömer K, Bayramoğlu M. Comparison of the efficacy of physical therapy and corticosteroid injection in the treatment of pes anserine tendino-bursitis. J Phys Ther Sci. 2016. PMID: 27512249.
  11. 11.Khodaee M. Common Superficial Bursitis. Am Fam Physician. 2017. PMID: 28290630.
  12. 12.Le Manac'h AP, Ha C, Descatha A, Imbernon E, Roquelaure Y. Prevalence of knee bursitis in the workforce. Occup Med (Lond). 2012. PMID: 22778241.
  13. 13.Bliddal H, Bays H, Czernichow S, Uddén Hemmingsson J, Hjelmesæth J, Hoffmann Morville T, et al. Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. N Engl J Med. 2024. PMID: 39476339.

Hip Bursitis and Body Weight: What the Evidence Shows

Most hip bursitis is gluteal tendinopathy, and it is about three times more common in women. What the evidence says about BMI as a risk factor, whether losing weight helps, and how exercise compares with a steroid injection.

10 min read

Rotator Cuff Tears, Weight and Diabetes: Symptoms, Repair Risks and Evidence

Rotator cuff tear symptoms, and how obesity and diabetes affect the risk of a tear and of a failed repair. Evidence on blood sugar control, physiotherapy versus surgery, whether losing weight helps, and the conflicting GLP-1 database studies.

11 min read

Meralgia Paresthetica and Body Weight: Causes, Treatment and Evidence

What causes meralgia paresthetica, the outer-thigh numbness and burning from a pinched nerve at the hip? Evidence on obesity, tight waistbands and pregnancy, cases after rapid or bariatric weight loss, whether losing weight helps, and how well treatments work.

10 min read

Wegovy Joint and Muscle Pain: What the Evidence Actually Shows

Does Wegovy cause joint or muscle pain? Arthralgia is uncommon and usually indirect, and the STEP 9 trial showed semaglutide reduced knee osteoarthritis pain.

9 min read

GLP-1 for Knee Osteoarthritis: STEP-9 Evidence + Surgery Bridge

STEP-9 (Bliddal 2024 NEJM) showed semaglutide reduced WOMAC pain scores in knee OA patients with obesity. We review the trial outcomes, the joint-replacement bridge, and the practical orthopedic + obesity medicine pathway.

11 min read

Diabetes Weight Loss Drug — Which Is Which? Untangling Ozempic, Mounjaro, Wegovy, Zepbound, Foundayo (2026)

Confused by all the GLP-1 brand names? Ozempic and Mounjaro are FDA-approved for type 2 diabetes. Wegovy, Zepbound, Foundayo, and Saxenda are FDA-approved for chronic weight management. Some share active ingredients with different brand names. This is the short, plain-English untangling — which drug is for diabetes, which is for weight loss, and what insurance will and will not cover.

7 min read

Where to get semaglutide (Ozempic / Wegovy) safely: vetted online providers

Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.3

Found

Mainstream telehealth GLP-1 access

8.1

GobyMeds

Budget-conscious shoppers

8.1

Oak

Compounded semaglutide and tirzepatide at a flat monthly price